Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer

被引：3

作者：

Classe, J. -M. ^{[1
]}

Muller, M. ^{[2
]}

Frenel, J. -S. ^{[3
]}

Rigaud, D. Berton ^{[3
]}

Ferron, G. ^{[4
]}

Jaffre, I. ^{[1
]}

Gladieff, L. ^{[5
]}

机构：

[1] Ctr Rene Gauducheau, Dept Chirurg Oncol, F-44805 St Herblain, France

[2] CHU Nantes, Dept Chirurg Oncol, F-44 Nantes, France

[3] Ctr Rene Gauducheau, Dept Med Oncol, F-44805 St Herblain, France

[4] Inst Claudius Regaud, Dept Chirurg Oncol, Toulouse, France

[5] Inst Claudius Regaud, Dept Med Oncol, Toulouse, France

来源：

JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2010年 / 39卷 / 03期

关键词：

Advanced ovarian cancer; Intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC PERITONEAL PERFUSION; HIGH-DOSE CARBOPLATIN; CYTOREDUCTIVE SURGERY; COMPLETE RESECTION; CARCINOMA PATIENTS; PHASE-II; CISPLATIN; RECURRENT; THERAPY; PACLITAXEL;

D O I：

10.1016/j.jgyn.2009.12.007

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The standard treatment for advanced ovarian cancer consist in complete surgical debulking and intravenous platin and taxane based chemotherapy. Despite research efforts, a lot of patients still die from peritoneal carcinomatosis. The aim of our work was to present the state of art about intraperitoneal chemotherapy. Intraperitoneal chemotherapy (IPC): three multi-institutional randomised trials showed that platin based IPC gave better results in term of overall and disease free survival when compared to standard intravenous treatment. Even so, IPC is not yet becoming a new international standard of treatment because a high rate of morbidity. Hyperthermic Intraperitoneal chemotherapy (HIPEC) represents an innovative alternative to IPC. HIPEC is based on a complete surgical debulking without any visible mass and an intraperitoneal chemotherapy with synergy of hyperthermia. Phase II trails have shown its feasibility. Randomised trials are needed to assess its efficiency in improving survival. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：183 / 190

页数：8

共 50 条

[1] Significance of intraperitoneal Chemotherapy in advanced Ovarian Cancer
Keyver-Paik, Mignon-Denise
Abramian, Alina
Kuhn, Walter
GEBURTSHILFE UND FRAUENHEILKUNDE, 2013, 73 (11) : 1078 - 1083
[2] Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
Wu, Tao
Zhao, Xi-Xia
Wang, Guo-Qing
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (04)
[3] INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER
LUCAS, WE
MARKMAN, M
HOWELL, SB
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 152 (04) : 474 - 478
[4] Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Ko, Jieun
Ha, Hyeong In
Choi, Min Chul
Jung, Sang Geun
Park, Hyun
Joo, Won Duk
Song, Seung Hun
Lee, Chan
Lee, Joon Mo
OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (05) : 437 - 443
[5] Intraperitoneal chemotherapy in the treatment of ovarian cancer
Kavanagh, John J.
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (07) : 541 - 542
[6] Intraperitoneal chemotherapy in the treatment of ovarian cancer
Markman, M
ANNALS OF MEDICINE, 1996, 28 (04) : 293 - 296
[7] Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer
Wang, Joyce Y.
Gross, Maya
Urban, Renata R.
Jorge, Soledad
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, : 313 - 329
[8] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
Massard, Christophe
Lhomme, Catherine
Pautier, Patricia
BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
[9] Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Venkatappa, Shalini
OBSTETRICS & GYNECOLOGY SCIENCE, 2022, 65 (01) : 103 - 104
[10] A regimen of outpatient intraperitoneal chemotherapy for advanced ovarian cancer
Berry, E.
Matthews, K. S.
Whitworth, J. M.
Kendrick, J. E.
Straughn, J. M.
Alvarez, R. D.
Singh, D. K.
Buttin, B. M.
Lurain, J. R.
Schink, J. C.
GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S15 - S15

← 1 2 3 4 5 →